A Novel Model of Intravital Platelet Imaging Using CD41-ZsGreen1 Transgenic Rats
Platelets play pivotal roles in both hemostasis and thrombosis. Although models of intravital platelet imaging are available for thrombosis studies in mice, few are available for rat studies. The present effort aimed to generate fluorescent platelets in rats and assess their dynamics in a rat model...
Saved in:
Published in | PloS one Vol. 11; no. 4; p. e0154661 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Public Library of Science
29.04.2016
Public Library of Science (PLoS) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Platelets play pivotal roles in both hemostasis and thrombosis. Although models of intravital platelet imaging are available for thrombosis studies in mice, few are available for rat studies. The present effort aimed to generate fluorescent platelets in rats and assess their dynamics in a rat model of arterial injury. We generated CD41-ZsGreen1 transgenic rats, in which green fluorescence protein ZsGreen1 was expressed specifically in megakaryocytes and thus platelets. The transgenic rats exhibited normal hematological and biochemical values with the exception of body weight and erythroid parameters, which were slightly lower than those of wild-type rats. Platelet aggregation, induced by 20 μM ADP and 10 μg/ml collagen, and blood clotting times were not significantly different between transgenic and wild-type rats. Saphenous arteries of transgenic rats were injured with 10% FeCl3, and the formation of fluorescent thrombi was evaluated using confocal microscopy. FeCl3 caused time-dependent increases in the mean fluorescence intensity of injured arteries of vehicle-treated rats. Prasugrel (3 mg/kg, p.o.), administered 2 h before FeCl3, significantly inhibited fluorescence compared with vehicle-treated rats (4.5 ± 0.4 vs. 14.9 ± 2.4 arbitrary fluorescence units at 30 min, respectively, n = 8, P = 0.0037). These data indicate that CD41-ZsGreen1 transgenic rats represent a useful model for intravital imaging of platelet-mediated thrombus formation and the evaluation of antithrombotic agents. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Competing Interests: JAJ is an employee and minor shareholder of Eli Lilly and Company. Other authors are the employees of Daiichi Sankyo Co., Ltd. Daiichi Sankyo Co., Ltd. has patents of prasugrel hydrochloride, and Daiichi Sankyo Co., Ltd. and Eli Lilly and Company have marketed products of prasugrel hydrochloride. They do not alter the authors’ adherence to PLOS ONE policies on sharing data and materials. Conceived and designed the experiments: MM AT KO AS. Performed the experiments: MM AT. Analyzed the data: MM AT KO JAJ AS. Contributed reagents/materials/analysis tools: MM AT. Wrote the paper: MM AT KO JAJ AS. |
ISSN: | 1932-6203 1932-6203 |
DOI: | 10.1371/journal.pone.0154661 |